AKAlireza Khalaj

Alireza Khalaj

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alireza Khalaj has a total of 89 co-authors. Here are the top co-authors by number of shared publications:

  • Maryam Barzin

    Obesity Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Science, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran

    9 shared publications
  • Farhad Hosseinpanah

    Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    6 shared publications
  • Golaleh Asghari

    Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    6 shared publications
  • Majid Valizadeh

    Obesity Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Science, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran

    6 shared publications
  • Maryam Zarkesh

    Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Molecular Biology, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    6 shared publications
  • Parvin Mirmiran

    Nutrition and Endocrine Research Center, Research Institute for Endocrine Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    6 shared publications

Latest Publications

  • Open Access

    Impact of high-intensity interval training vs. moderate-intensity continuous training combined with strength training on physical and metabolic outcomes in post-bariatric surgery patients with sarcopenic obesity

    by Mastaneh Rajabian Tabesh, Fatemeh Shabkhiz, Alireza Khalaj, Maryam Mousavi, Maryam Abolhasani, Rahman Soori

    Background: Sarcopenic obesity (SO) is a pathological condition characterized by a decline in skeletal muscle mass accompanied by increased fat accumulation. This condition is associated with a higher risk of physical limitations, cardiovascular diseases, and weight loss failure following bariatric surgery (BS). To identify more effective management strategies for SO after BS, this study aimed to compare the effects of high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) on body composition parameters, physical performance, and cardiometabolic indicators in patients with SO post-BS. Methods: In this study, 80 females with body mass index 40 ≤ BMI ≤ 50 kg/m2 who were candidates for undergoing BS and diagnosed with SO were recruited. Participants were divided into two groups: HIIT ( n = 40) and MICT ( n = 40), each further subdivided into sleeve ( n = 20) and bypass ( n = 20). Both interventions were followed over an 8-week period after BS, starting from four to 12 weeks post-surgery. Body composition (Weight, Fat Mass, Skeletal Muscle Mass, and Fat Free Mass), physical performance (aerobic capacity, physical ability, and muscle strength), and cardiometabolic indicators (glycemic indicators, lipid profile, and inflammatory factors) were measured pre and post intervention using body impedance analyzer, standardized functional tests, and blood samples, respectively. A 24-hour food diary was also obtained by conducting an in-person interview for food intake assessment. Results: A total of 80 participants completed the study. Age was a significant covariate ( p = .007). After adjusting for age, HIIT significantly reduced weight, BMI, calorie intake, and carbohydrate intake compared to MICT, with the HIIT-bypass group showing significant improvements in HbA1c, insulin, and FBS (mean reduction of 7.71%, 24.98%, and 6.34%, respectively; p < .05). Additionally, HIIT-bypass reduced hs-CRP (mean reduction of 23.81%) and increased HDL (mean increase of 8.88%) ( p < .001). In terms of physical performance, while HIIT in both the sleeve and bypass groups significantly improved Sit-to-Stand performance (+ 26.97% for sleeve and + 27.47% for bypass, p < .05), the HIIT-sleeve group showed the greatest improvements in walking speed and balance test (mean increase of 10.33% and 14.59%, respectively, p < .001), whereas HIIT-bypass exhibited the most significant improvement in Timed Up-and-Go (+ 12.21%, p < .001). These findings highlight the superior effectiveness of HIIT over MICT (dependent on the type of surgery) in improving both metabolic and some physical outcomes. Conclusion: Significant differences were observed in cardiometabolic and physical performance parameters between the two training protocols. HIIT resulted in significant improvements in aerobic capacity, physical ability, glycemic indicators, hs-CRP, HDL, weight, BMI, and food intakes compared to MICT. These findings may position HIIT as a promising intervention for optimizing metabolic and physical outcomes in post-bariatric patients with sarcopenic obesity. However, no significant changes were observed in muscle strength or skeletal muscle mass. These findings position HIIT as a promising intervention for optimizing certain metabolic and physical outcomes in this population, though further blinded, randomized controlled trials are warranted to confirm these results. Authorized ethics committees Number: IR.TUMS.THC.REC.1401.052. Trial registration: Current research is a prospective quasi-experimental study, and clinical trial number is not applicable.


  • Bariatric Surgery and Renal Function: A Mid-Term Prospective Analysis of Estimated Glomerular Filtration Rate Dynamics in Adults with and without Diabetes Mellitus

    by Seyed Amirhossein Fazeli, Narges Khodadadi, Sara Sadeghi, Farhad Hosseinpanah, Maryam Mahdavi, Majid Valizadeh, Maryam Tohidi, Alireza Khalaj, Maryam Barzin

    Background Obesity is associated with a range of medical problems, including impaired renal function. Type 2 diabetes mellitus (T2DM), independently, exerts a direct and multifactorial impact on renal health. This study evaluates and compares the effects of metabolic bariatric surgery (MBS) on renal function in patients with and without T2DM. Methods This prospective cohort study followed patients undergoing MBS over three years, stratified by T2DM status. Participants were matched using propensity scores (PS), and postoperative trajectories of creatinine-based estimated glomerular filtration rate (eGFR) were compared. Generalized estimating equation (GEE) method was employed to identify factors significantly associated with changes in eGFR over time. Results A total of 1895 participants (83% women), including 770 PS-matched individuals, were enrolled in the study. All participants had a baseline eGFR ≥ 60 mL/min/1.73m2. Across both unmatched and matched cohorts, and irrespective of T2DM status, eGFR improved over the three-year follow-up, with no significant between-group differences or interactions observed. Multivariable analysis identified older age, being a woman, higher baseline eGFR, and undergoing sleeve gastrectomy (SG) as negative correlates of eGFR improvements over time. Conclusion Renal function improved following MBS, regardless of T2DM status. Furthermore, older age, being a woman, higher baseline eGFR, and undergoing SG were associated with less eGFR improvements.

  • Metabolic and Bariatric Surgery Evolution Over the Past Decades (2009–2024): Insights from the Iranian National Obesity Surgery Database (INOSD)

    by Shahab Shahabi Shahmiri, Abdolreza Pazouki, Seyed Amin Setarehdan, Kimia Vakili, Kimia Jazi, Erfan Sheikhbahaei, Fahime Yarigholi, Somayeh Mokhber, Alireza Khalaj, Amir Hossein Davarpanah Jazi, et al.

    Background Over the past three decades, metabolic and bariatric surgery (MBS) has undergone significant changes in Iran, mirroring global trends and incorporating regional innovations. This study aims to investigate MBS trends in Iran over 15 years (2009–2024), with a focus on demographic patterns and procedural distribution. Methods Data from the Iranian National Obesity Surgery Database (INOSD) provided the basis for a retrospective study. The study encompassed all patients with MBS between 2009 and 2024. The demographic traits, body mass index (BMI), obesity-associated medical disease, surgical operation type, and trends over time were analyzed. Results In total, 55,936 patients were included, most of whom were female (80%). The majority (62%) were aged 25–45 years. With a declining number of patients with BMI > 50 kg/m² over time, most patients fell in the range of 40–50 kg/m². The most common obesity-associated medical problems were hypertension (15%), severe obstructive sleep apnea (12%), type 2 diabetes mellitus (11%), and dyslipidemia (11%). Rising from 2.6% in 2009 to 56% in 2024, sleeve gastrectomy (SG) surpassed Roux-en-Y gastric bypass (RYGB), which decreased from 92% in 2009 to 13% in 2024. Especially in higher BMI patients, one anastomosis gastric bypass (OAGB) demonstrated a consistent rise. Rates of revisional and conversional surgery rose over time, specifically in OAGB. Conclusions With an increasing inclination for SG and OAGB, MBS trends in Iran mirror a worldwide movement toward safer and more effective treatments. Graphical Abstract

  • Comparative Effectiveness of Sleeve Gastrectomy and One-Anastomosis Gastric Bypass on Cardiovascular Disease Risk: Insights from a Prospective Cohort Study

    by Sara Sadeghi, Farhad Hosseinpanah, Maryam Mahdavi, Danial Molavizadeh, Majid Valizadeh, Alireza Khalaj, Maryam Barzin

    Aims This study compares the effectiveness of sleeve gastrectomy (SG) and one-anastomosis gastric bypass (OAGB) on the predicted 10-year atherosclerotic cardiovascular disease (ASCVD) risk and identifies key factors influencing postoperative (post-op) changes in ASCVD risk. Methods This prospective cohort study assessed the 10-year ASCVD risk in patients undergoing SG or OAGB between 2013 and 2023 using the ACC/AHA ASCVD Risk Estimator. In addition to the baseline assessment, the risk score was evaluated at 6, 12, 24, 36, and 48 months post-op. Longitudinal analysis tracked changes in ASCVD risk, and regression models identified individual and combined factors influencing these changes. Results The analysis enrolled 1397 individuals (mean age 50.1 years, 87.9% female), including 952 SG and 445 OAGB participants. Following adjustments, the 10-year ASCVD risk significantly reduced post-op with no observed differences between the surgical groups. Positive associations with risk reduction were found for baseline risk, total cholesterol (TC), type 2 diabetes mellitus (T2DM), triglycerides (TG), systolic blood pressure (SBP), fasting plasma glucose (FPG), and estimated glomerular filtration rate (eGFR). In contrast, age, triglyceride-glucose (TyG) index, hemoglobin A1c (HbA1c), male sex, smoking, and high-density lipoprotein cholesterol (HDL-C) demonstrated negative associations with ASCVD risk reduction. Conclusion Metabolic and bariatric surgery significantly reduced the 10-year ASCVD risk, with comparable outcomes between SG and OAGB. Key determinants influencing the 10-year ASCVD risk reduction included baseline risk score, age, TC, T2DM, TyG index, TG, HbA1c, SBP, sex, FPG, smoking, HDL-C, and eGFR.


  • Associations between dietary and lifestyle insulinemic indices and cardiometabolic risk factors in adults undergoing abdominal surgery

    by Hamid Ahmadirad, Hossein Farhadnejad, Farshad Teymoori, Ghazaleh Shimi, Ebrahim Mokhtari, Golaleh Asghari, Emad Yuzbashian, Parvin Mirmiran, Maryam Zarkesh, Alireza Khalaj

    Purpose The present study investigated the association of insulinemic indices including dietary (DIH) and lifestyle (LIH) insulinemic indices for hyperinsulinemia, as well as dietary (DIR) and lifestyle (LIR) insulinemic indices for insulin resistance with cardiometabolic factors, including the waist circumference (WC), hip circumference (HC), systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting blood sugar (FBS), triglycerides, total cholesterol(TC), and insulin level. Methods A total of 176 individuals, aged 18 to 84, took part in this cross-sectional study. The food frequency questionnaire was used to record individuals’ dietary intake data and calculate insulinemic indices. Associations between these indices and cardiometabolic factors were evaluated using linear regression, and results were presented as unstandardized β values with 95% confidence intervals. Results In the final adjusted model, participants with a body mass index (BMI) < 30 kg/m2 exhibited a positive association between the LIH and LIR scores and the FBS levels. Among participants with BMI ≥ 30 kg/m2, positive associations were observed between LIH and LIR scores with WC and HC. Additionally, a direct association was found between the scores of DIR and FBS levels. Among all participants, there were positive associations between LIH and LIR scores with levels of SBP, DBP, WC, HC, and insulin. Conclusions Greater adherence to a diet and lifestyle characterized by higher DIR, LIH, and LIR scores was positively associated with elevated levels of cardiometabolic factors, including SBP, DBP, WC, HC, and insulin.

  • Emotional and External Eating Behaviors Associated with Fat-Free Mass Loss Following Sleeve Gastrectomy

    by Nazanin Moslehi, Zahra Kamali, Maryam Barzin, Alireza Khalaj, Parvin Mirmiran

    Background Rapid weight loss after metabolic bariatric surgery may lead to excessive fat-free mass (FFM) loss, potentially reducing the procedure’s health benefits. This study aimed to investigate the association between eating behaviors and FFM loss as well as total weight loss (TWL) at midterm (about 2–4 years) following sleeve gastrectomy (SG). Methods This cross-sectional study included 146 adults assessed approximately 2–4 years post-SG. Eating behaviors were evaluated using the Dutch Eating Behavior Questionnaire. The proportion of FFM loss relative to TWL (%FFML) was calculated, with excessive FFM loss defined as the highest tertile of %FFML (≥ 28%). The associations between eating behaviors and %FFML and %TWL were analyzed using linear regression models. Logistic regression was employed to estimate the odds ratios (95% confidence intervals (CIs)) for excessive FFM loss and suboptimal clinical response (TWL < 20%). Results The mean time since SG was 30.8 ± 6.5 months, and 77.4% of participants were women. In the multivariable-adjusted model, emotional eating (B = 1.71; 95% CI 0.17, 3.25) and external eating (B = 1.76; 95% CI 0.01, 3.51) were associated with higher %FFML. The adjusted odds ratio (95% CI) for excessive FFM loss per unit increase was 2.28 (1.41, 3.70) for emotional eating and 1.84 (1.08, 3.15) for external eating. Eating behaviors were not significantly associated with %TWL or suboptimal clinical response. Conclusions Emotional and external eating behaviors were independently associated with greater proportional FFM loss and increased odds of excessive FFM loss at midterm post-SG, though they were not linked to %TWL.


  • Open Access

    The relationship between dietary branched-chain and aromatic amino acids with the regulation of leptin and FTO genes in adipose tissue of patients undergoing abdominal surgery

    by Farshad Teymoori, Hossein Farhadnejad, Mostafa Norouzzadeh, Mitra Kazemi Jahromi, Niloufar Saber, Ebrahim Mokhtari, Golaleh Asghari, Emad Yuzbashian, Parvin Mirmiran, Alireza Khalaj, et al.

    Recent studies have suggested that the interaction between diet and an individual’s genetic predisposition can determine the likelihood of obesity and various metabolic disorders. The current study aimed to examine the association of dietary branched-chain amino acids(BCAAs) and aromatic amino acids(AAAs) with the expression of the leptin and FTO genes in the visceral and subcutaneous adipose tissues of individuals undergoing surgery. This cross-sectional study was conducted on 136 Iranian adults, both men and women, aged ≥18 years. The samples were selected from patients admitted for abdominal surgeries. The dietary intake of BCAAs and AAAs was determined using a valid and reliable 168-item food frequency questionnaire. Using the quantitative PCR method, leptin and FTO mRNA expression was measured in both visceral and subcutaneous fat tissues. The mean age of the participants was 39.8 ± 12.7 years, and the mean intake of BCAAs and AAAs was 17.7 ± 0.9 and 9.3 ± 0.3% of protein per day, respectively. In overweight-obese patients(body mass index = 25–34.9 kg/m2), the intake of BCAAs(β:-0.75,95%CI:-1.47,-0.03), valine(β:-0.78,95%CI:-1.51,-0.05), and tyrosine(β:-0.81,95%CI:-1.55,-0.06) was inversely associated with FTO gene expression in subcutaneous fat tissue in adjusted model. In morbidly obese patients(body mass index ≥ 35 kg/m2), a higher intake of total BCAAs(β:1.10,95%CI:0.07–2.13), leucine(β:1.07,95%CI:0.03–2.13), and isoleucine(β:1.49,95%CI:0.46–2.52) was associated with an increase of leptin gene expression in subcutaneous fat tissue. Our findings suggest that dietary BCAA may associated with gene expression in adipose tissues, potentially influencing obesity-related metabolic pathways. Further prospective studies are warranted to validate results and elucidate the potential for dietary interventions targeting amino acids intake in obesity management.


  • Thyroid Hormone Replacement Dosing after Bariatric Surgery in Patients with Primary Hypothyroidism And Severe Obesity: Tehran Obesity Treatment Study

    by Maryam Barzin, Danial Molavizadeh, Maryam Mahdavi, Alireza Khalaj, Sara Sadeghi, Majid Valizadeh, Fereidoun Azizi, Farhad Hosseinpanah

    Background: Obesity and hypothyroidism are common medical conditions that are associated with each other. Bariatric surgery (BS) is a common approach used to achieve substantial weight loss in obese patients. However, there is limited evidence regarding the need for postsurgery levothyroxine (LT4) dose adjustment in patients with hypothyroidism undergoing BS. Methods: This was a three-year prospective cohort study assessing postsurgery LT4 requirements with attention to body composition changes. The current study included 1030 patients with hypothyroidism, who underwent sleeve gastrectomy (SG) ( n = 707, 88.3% women) or one anastomosis gastric bypass (OAGB) ( n = 323, 92% women). Patients were followed for 36 months after surgery. A bioelectrical impedance analyzer was used for body composition assessment. LT4 requirements were assessed by generalized estimating equation (GEE) methods adjusted for weight as a time-varying covariate. Results: During the follow-up, TSH (mIU/L) and T4 (ng/dL) measurements did not significantly change in the OAGB group over time. However, in the SG group, TSH measurement decreased over time ( p trend = p trend = 0.039)] and OAGB [1.7 (1.4–2.2) to 3.2 (2.7–4.8), p trend = p between = 0.060). In both groups, after the first year, the increase in LT4/FM (μg/kg) plateaued ( p interaction = 0.009). Conclusion: Most hypothyroid patients experienced either a reduction or no change in LT4 (μg/day) dosage after 36 months in both surgical groups. The LT4/FM (μg/kg) was significantly increased in patients undergoing either SG or OAGB with greater alterations in the latter. Further studies on larger populations and with longer duration of follow-up are needed to confirm our results.


  • Open Access

    What About My Weight? Insufficient Weight Loss or Weight Regain After Bariatric Metabolic Surgery

    by Hamidreza Zefreh, Reza Amani-Beni, Erfan Sheikhbahaei, Farnaz Farsi, Shahrzad Ahmadkaraji, Maryam Barzin, Bahar Darouei, Alireza Khalaj, Shahab Shahabi

    Context: This review study aimed to investigate the definition, etiology, risk factors (RFs), management strategy, and prevention of insufficient weight loss (IWL) and weight regain (WR) following bariatric metabolic surgery (BMS). Evidence Acquisition: Electronic databases were searched to retrieve relevant articles. The inclusion criteria were English articles with adult participants assessing the definition, prevalence, etiology, RFs, management strategy, and prevention of IWL/WR. Results: Definition: The preferred definition for post-BMS IWL/WR are the terms "Lack of maintenance of total weight loss (TWL)>20%" and "weight change in percentage compared to nadir weight or weight loss". Prevalence: The exact prevalence of IWL/WR is still being determined due to the type of BMS and various definitions. Etiology: Several mechanisms, including hormonal/metabolic, dietary non-adherence, physical inactivity, mental health, and anatomic surgical failure, are possible etiologies of post-BMS IWL/WR. RFs: Preoperative body mass index (BMI), male gender, psychiatric conditions, comorbidities, age, poor diet, eating disorders, poor follow-ups, insufficient physical activity, micronutrients, and genetic-epigenetic factors are the most important RFs. Management Strategy: The basis of treatment is lifestyle interventions, including dietary, physical activity, psychological, and behavioral therapy. Pharmacotherapy can be added. In the last treatment line, different techniques of endoscopic surgery and revisional surgery can be used. Prevention: Behavioral and psychotherapeutic interventions, dietary therapy, and physical activity therapy are the essential components of prevention. Conclusions: Many definitions exist for WR, less so for IWL. Etiologies and RFs are complex and multifactorial; therefore, the management and prevention strategy is multidisciplinary. Some knowledge gaps, especially for IWL, exist, and these gaps must be filled to strengthen the evidence used to guide patient counseling, selection, and improved outcomes.